Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
July-2025 Volume 30 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2025 Volume 30 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

In vitro and in silico investigation of the critical role of GABAB receptor activation in human breast cancer and its natural agonists

  • Authors:
    • Mustafa Hussein Ali
    • Ziyad Tariq Muhseen
    • Zahraa Yousif Al-Hajjaj
    • Hussein Hazim Al-Ghanimi
    • Abdulrahman Alshammari
    • Norah Abdullah Albekairi
  • View Affiliations / Copyright

    Affiliations: State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu 210023, P.R. China, Department of Molecular Biology, Iraqi Center for Cancer and Medical Genetic Research, Mustansiriyah University, Baghdad 10064, Iraq, Department of Anesthesia Techniques and Intensive Care, Al Taff University College, Karbala 56001, Iraq, Department of Biomedical Engineering, College of Engineering, University of Warith Al-Anbiyaa, Karbala 56001, Iraq, Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
    Copyright: © Ali et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 357
    |
    Published online on: May 21, 2025
       https://doi.org/10.3892/ol.2025.15103
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

γ‑aminobutyric acid type B (GABAB) receptors, a class of G protein‑coupled receptors, serve pivotal roles in modulating cellular signaling pathways across both neural and peripheral tissues, although their underlying mechanisms involved in cancer progression have yet to be fully elucidated. The aim of the present study was to investigate the effect of GABAB receptor activation on the migration, invasion, clonogenicity, proliferation and epithelial‑mesenchymal transition (EMT) of the MDA‑MB‑231 human breast cancer cell line. To meet this aim, MDA‑MB‑231 cells were treated with various concentrations of the GABAB receptor agonist, baclofen. Treatment with baclofen caused a significant inhibition of cell migration, invasion and clonogenicity in a dose‑dependent manner. Moreover, baclofen treatment led to a downregulation of vimentin expression, whereas the expression of β‑catenin was upregulated, indicating suppression of EMT in MDA‑MB‑231 cells. Notably, the phosphorylation levels of Akt and ERK1/2 remained unaltered, suggesting that the inhibitory effects mediated by baclofen on EMT were not mediated via either the phosphoinositide 3‑kinase/Akt or the MAPK pathways. To identify potential natural GABAB receptor agonists, molecular docking techniques were employed using the MPD3 database. This in silico approach revealed three compounds (PubChem identification, 450432, 6448 and 6057) as promising candidates, which all exhibited critical hydrogenbond interactions with the GABAB receptorbinding site. These compounds may serve as lead compounds for developing novel, naturally derived GABAB receptor agonists. Taken together, the findings demonstrated that GABAB receptor activation via baclofen inhibits multiple aggressive phenotypes in MDA‑MB‑231 breast cancer cells. Moreover, these results offer promising avenues for developing GABAB receptor agonists as a therapeutic strategy in breast cancer treatment.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, Brooks D, Creasman W, Cohen C, Runowicz C, et al: American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers: Also: Update 2001-testing for early lung cancer detection. CA Cancer J Clin. 51:38–75. 2001. View Article : Google Scholar : PubMed/NCBI

2 

Siegel RL, Miller KD, Wagle NS and Jemal A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48. 2023. View Article : Google Scholar : PubMed/NCBI

3 

Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan K, Brown NJ, Bryant HE, et al: Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res. 15:R922013. View Article : Google Scholar : PubMed/NCBI

4 

Memon MA, Abbasi F, Abbasi IHR, Mughal GA, Soomro RN and Memon AS: Surgical approaches to cat breast cancer (Mammary tumor), their treatment and management at Richmond Crawford Veterinary Hospital Karachi (RCVH), Sindh, Pakistan. ARC J Animal and Veterinary Sciences (AJAVS). 2:23–28. 2016.

5 

Chang JW, Ding Y, Ul Qamar MT, Shen Y, Gao J and Chen LL: A deep learning model based on sparse autoencoder for prioritizing cancerrelated genes and drug target combinations. Carcinogenesis. 40:624–632. 2019. View Article : Google Scholar : PubMed/NCBI

6 

Wang Y, Shi J, Chai K, Ying X and Zhou BP: The role of snail in EMT and tumorigenesis. Curr Cancer Drug Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI

7 

KudoSaito C, Shirako H, Ohike M, Tsukamoto N and Kawakami Y: CCL2 is critical for immunosuppression to promote cancer metastasis. Clin Exp Metastasis. 30:393–405. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Liang H, Yu T, Han Y, Jiang H, Wang C, You T, Zhao X, Shan H, Yang R, Yang L, et al: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR1013p to regulate ZEB1 expression. Mol Cancer. 17:1192018. View Article : Google Scholar : PubMed/NCBI

9 

Tania M, Khan MA and Fu J: Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer. Tumor Biol. 35:7335–7342. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Chen KF, Chen HL, Tai WT, Feng WC, Hsu CH, Chen PJ and Cheng AL: Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. J Pharmacol Exp Ther. 337:155–161. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Noorolyai S, Shajari N, Baghbani E, Sadreddini S and Baradaran B: The relation between PI3K/AKT signalling pathway and cancer. Gene. 698:120–128. 2019. View Article : Google Scholar : PubMed/NCBI

12 

Mahajan K and Mahajan NP: PI3K-independent AKT activation in cancers: A treasure trove for novel therapeutics. J Cell Physiol. 227:3178–3184. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Vithlani M, Terunuma M and Moss SJ: The dynamic modulation of GABAA receptor trafficking and its role in regulating the plasticity of inhibitory synapses. Physiol Rev. 91:1009–1022. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Tian H, Wu JX, Shan FX, Zhang SN, Cheng Q, Zheng JN and Pei DS: Gamma aminobutyric acid induces tumor cells apoptosis via GABABR1·β-arrestins·JNKs signaling module. Cell Biochem Biophys. 71:679–688. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Tatsuta M, Ishi H, Baba M, Nakaizumi A, Ichii M and Taniguchi H: Inhibition by γ-amino-n-butyric acid and baclofen of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res. 50:4931–4934. 1990.PubMed/NCBI

16 

Gao J, Gao Y, Lin S, Zou X, Zhu Y, Chen X, Wan H and Zhu H: Effects of activating GABAB1 receptor on proliferation, migration, invasion and epithelialmesenchymal transition of ovarian cancer cells. J Ovarian Res. 13:1262020. View Article : Google Scholar : PubMed/NCBI

17 

Kanbara K, Otsuki Y, Watanabe M, Yokoe S, Mori Y, Asahi M and Neo M: GABA B receptor regulates proliferation in the highgrade chondrosarcoma cell line OUMS27 via apoptotic pathways. BMC Cancer. 18:2632018. View Article : Google Scholar : PubMed/NCBI

18 

Solorzano SR, ImazRosshandler I, CamachoArroyo I, García-Tobilla P, Morales-Montor G, Salazar P, Arena-Ortiz ML and Rodríguez-Dorantes M: GABA promotes gastrinreleasing peptide secretion in NE/NElike cells: Contribution to prostate cancer progression. Sci Rep. 8:102722018. View Article : Google Scholar : PubMed/NCBI

19 

Zhang D, Li X, Yao Z, Wei C, Ning N and Li J: GABAergic signaling facilitates breast cancer metastasis by promoting ERK1/2dependent phosphorylation. Cancer Lett. 348:100–108. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Trott O and Olson AJ: AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 31:455–461. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Sussman JL, Lin D, Jiang J, Manning NO, Prilusky J, Ritter O and Abola E: Protein data bank (PDB): Database of threedimensional structural information of biological macromolecules. Acta Crystallogr D Biol Crystallogr. 54:1078–1084. 1998. View Article : Google Scholar : PubMed/NCBI

22 

Mumtaz A, Ashfaq U, Qamar M, Anwar F, Gulzar F, Ali MA, Saari N and Pervez MT: MPD3: A useful medicinal plants database for drug designing. Nat Prod Res. 31:1228–1236. 2016. View Article : Google Scholar : PubMed/NCBI

23 

O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T and Hutchison GR: Open babel: An open chemical toolbox. J Cheminform. 3:332011. View Article : Google Scholar : PubMed/NCBI

24 

Lodewyks C, Rodriguez J, Yan J, Lerner B, Lipschitz J, Nfon C, Rempel JD, Uhanova J and Minuk GY: GABAB receptor activation inhibits the in vitro migration of malignant hepatocytes. Can J Physiol Pharmacol. 89:393–400. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Jolly MK and Celià-Terrassa T: Dynamics of phenotypic heterogeneity associated with EMT and stemness during cancer progression. J Clin Med. 8:15422019. View Article : Google Scholar : PubMed/NCBI

26 

Zhou P, Li B, Liu F, Zhang M, Wang Q, Liu Y, Yao Y and Li D: The epithelial to mesenchymal transition (EMT) and cancer stem cells: Implication for treatment resistance in pancreatic cancer. Mol Cancer. 16:522017. View Article : Google Scholar : PubMed/NCBI

27 

Myers AP and Cantley LC: Targeting a common collaborator in cancer development. Sci Transl Med. 2:48ps452010. View Article : Google Scholar : PubMed/NCBI

28 

Tu H, Xu C, Zhang W, Liu Q, Rondard P, Pin JP and Liu J: GABAB receptor activation protects neurons from apoptosis via IGF-1 receptor transactivation. J Neurosci. 30:749–759. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Bowery NG, Doble A, Hill DR, Hudson AL, Shaw JS, Turnbull MJ and Warrington R: Bicucullineinsensitive GABA receptors on peripheral autonomic nerve terminals. Eur J Pharmacol. 71:53–70. 1981. View Article : Google Scholar : PubMed/NCBI

30 

Herman RM, D'Luzansky SC and Ippolito R: Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain. 8:338–345. 1992. View Article : Google Scholar : PubMed/NCBI

31 

Choudhari AS, Mandave PC, Deshpande M, Ranjekar P and Prakash O: Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Front Pharmacol. 10:16142020. View Article : Google Scholar : PubMed/NCBI

32 

Kirui JK, Xie Y, Wolff DW, Jiang H, Abel PW and Tu Y: Gbetagamma signaling promotes breast cancer cell migration and invasion. J Pharmacol Exp Ther. 333:393–403. 2010. View Article : Google Scholar : PubMed/NCBI

33 

Calver A, Medhurst A, Robbins M, Charles KJ, Evans ML, Harrison DC, Stammers M, Hughes SA, Hervieu G, Couve A, et al: The expression of GABAB1 and GABAB2 receptor subunits in the CNS differs from that in peripheral tissues. Neuroscience. 100:155–170. 2000. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ali MH, Muhseen ZT, Al-Hajjaj ZY, Al-Ghanimi HH, Alshammari A and Albekairi NA: <em>In vitro</em> and<em> in silico</em> investigation of the critical role of GABA<sub>B</sub> receptor activation in human breast cancer and its natural agonists. Oncol Lett 30: 357, 2025.
APA
Ali, M.H., Muhseen, Z.T., Al-Hajjaj, Z.Y., Al-Ghanimi, H.H., Alshammari, A., & Albekairi, N.A. (2025). <em>In vitro</em> and<em> in silico</em> investigation of the critical role of GABA<sub>B</sub> receptor activation in human breast cancer and its natural agonists. Oncology Letters, 30, 357. https://doi.org/10.3892/ol.2025.15103
MLA
Ali, M. H., Muhseen, Z. T., Al-Hajjaj, Z. Y., Al-Ghanimi, H. H., Alshammari, A., Albekairi, N. A."<em>In vitro</em> and<em> in silico</em> investigation of the critical role of GABA<sub>B</sub> receptor activation in human breast cancer and its natural agonists". Oncology Letters 30.1 (2025): 357.
Chicago
Ali, M. H., Muhseen, Z. T., Al-Hajjaj, Z. Y., Al-Ghanimi, H. H., Alshammari, A., Albekairi, N. A."<em>In vitro</em> and<em> in silico</em> investigation of the critical role of GABA<sub>B</sub> receptor activation in human breast cancer and its natural agonists". Oncology Letters 30, no. 1 (2025): 357. https://doi.org/10.3892/ol.2025.15103
Copy and paste a formatted citation
x
Spandidos Publications style
Ali MH, Muhseen ZT, Al-Hajjaj ZY, Al-Ghanimi HH, Alshammari A and Albekairi NA: <em>In vitro</em> and<em> in silico</em> investigation of the critical role of GABA<sub>B</sub> receptor activation in human breast cancer and its natural agonists. Oncol Lett 30: 357, 2025.
APA
Ali, M.H., Muhseen, Z.T., Al-Hajjaj, Z.Y., Al-Ghanimi, H.H., Alshammari, A., & Albekairi, N.A. (2025). <em>In vitro</em> and<em> in silico</em> investigation of the critical role of GABA<sub>B</sub> receptor activation in human breast cancer and its natural agonists. Oncology Letters, 30, 357. https://doi.org/10.3892/ol.2025.15103
MLA
Ali, M. H., Muhseen, Z. T., Al-Hajjaj, Z. Y., Al-Ghanimi, H. H., Alshammari, A., Albekairi, N. A."<em>In vitro</em> and<em> in silico</em> investigation of the critical role of GABA<sub>B</sub> receptor activation in human breast cancer and its natural agonists". Oncology Letters 30.1 (2025): 357.
Chicago
Ali, M. H., Muhseen, Z. T., Al-Hajjaj, Z. Y., Al-Ghanimi, H. H., Alshammari, A., Albekairi, N. A."<em>In vitro</em> and<em> in silico</em> investigation of the critical role of GABA<sub>B</sub> receptor activation in human breast cancer and its natural agonists". Oncology Letters 30, no. 1 (2025): 357. https://doi.org/10.3892/ol.2025.15103
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team